Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112

1.

Options for Improved Phosphorus Cycling and Use in Agriculture at the Field and Regional Scales.

Schneider KD, Thiessen Martens JR, Zvomuya F, Reid DK, Fraser TD, Lynch DH, O'Halloran IP, Wilson HF.

J Environ Qual. 2019 Sep;48(5):1247-1264. doi: 10.2134/jeq2019.02.0070. Review.

PMID:
31589712
2.

Ground and rove beetles (Coleoptera: Carabidae and Staphylinidae) are affected by mulches and weeds in highbush blueberries.

Renkema JM, Lynch DH, Cutler GC, Mackenzie K, Walde SJ.

Environ Entomol. 2012 Oct;41(5):1097-106. doi: 10.1603/EN12122.

PMID:
23068165
3.

Emergence of blueberry maggot flies (Diptera: tephritidae) from mulches and soil at various depths.

Renkema JM, Lynch DH, Cutler GC, Mackenzie K, Walde SJ.

Environ Entomol. 2012 Apr;41(2):370-6. doi: 10.1603/EN11200.

PMID:
22507011
4.

Avoidance tests with Folsomia candida for the assessment of copper contamination in agricultural soils.

Boiteau G, Lynch DH, Mackinley P.

Environ Pollut. 2011 Apr;159(4):903-6. doi: 10.1016/j.envpol.2010.12.023. Epub 2011 Jan 17.

PMID:
21247679
5.
6.

The promise of 4-1BB (CD137)-mediated immunomodulation and the immunotherapy of cancer.

Lynch DH.

Immunol Rev. 2008 Apr;222:277-86. doi: 10.1111/j.1600-065X.2008.00621.x. Review.

PMID:
18364008
7.

The CD95 receptor: apoptosis revisited.

Peter ME, Budd RC, Desbarats J, Hedrick SM, Hueber AO, Newell MK, Owen LB, Pope RM, Tschopp J, Wajant H, Wallach D, Wiltrout RH, Zörnig M, Lynch DH.

Cell. 2007 May 4;129(3):447-50.

8.

Quantitative measurement of nuclear translocation events using similarity analysis of multispectral cellular images obtained in flow.

George TC, Fanning SL, Fitzgerald-Bocarsly P, Medeiros RB, Highfill S, Shimizu Y, Hall BE, Frost K, Basiji D, Ortyn WE, Morrissey PJ, Lynch DH.

J Immunol Methods. 2006 Apr 20;311(1-2):117-29. Epub 2006 Mar 10. Erratum in: J Immunol Methods. 2009 May 15;344(1):85. Fitzgeral-Bocarsly, Patricia [corrected to Fitzgerald-Bocarsly, Patricia].

PMID:
16563425
9.

Inhibition of adenine nucleotide translocator pore function and protection against apoptosis in vivo by an HIV protease inhibitor.

Weaver JG, Tarze A, Moffat TC, Lebras M, Deniaud A, Brenner C, Bren GD, Morin MY, Phenix BN, Dong L, Jiang SX, Sim VL, Zurakowski B, Lallier J, Hardin H, Wettstein P, van Heeswijk RP, Douen A, Kroemer RT, Hou ST, Bennett SA, Lynch DH, Kroemer G, Badley AD.

J Clin Invest. 2005 Jul;115(7):1828-38.

10.

Nitrogen availability from composts for humid region perennial grass and legume-grass forage production.

Lynch DH, Voroney RP, Warman PR.

J Environ Qual. 2004 Jul-Aug;33(4):1509-20.

PMID:
15254133
11.

Distinguishing modes of cell death using the ImageStream multispectral imaging flow cytometer.

George TC, Basiji DA, Hall BE, Lynch DH, Ortyn WE, Perry DJ, Seo MJ, Zimmerman CA, Morrissey PJ.

Cytometry A. 2004 Jun;59(2):237-45.

12.

Differential effects of interleukin-7 and interleukin-15 on NK cell anti-human immunodeficiency virus activity.

Lum JJ, Schnepple DJ, Nie Z, Sanchez-Dardon J, Mbisa GL, Mihowich J, Hawley N, Narayan S, Kim JE, Lynch DH, Badley AD.

J Virol. 2004 Jun;78(11):6033-42.

13.

A switch in costimulation from CD28 to 4-1BB during primary versus secondary CD8 T cell response to influenza in vivo.

Bertram EM, Dawicki W, Sedgmen B, Bramson JL, Lynch DH, Watts TH.

J Immunol. 2004 Jan 15;172(2):981-8.

14.

HIV-1 protease processes procaspase 8 to cause mitochondrial release of cytochrome c, caspase cleavage and nuclear fragmentation.

Nie Z, Phenix BN, Lum JJ, Alam A, Lynch DH, Beckett B, Krammer PH, Sekaly RP, Badley AD.

Cell Death Differ. 2002 Nov;9(11):1172-84.

15.
16.
17.

Induction of cell death in human immunodeficiency virus-infected macrophages and resting memory CD4 T cells by TRAIL/Apo2l.

Lum JJ, Pilon AA, Sanchez-Dardon J, Phenix BN, Kim JE, Mihowich J, Jamison K, Hawley-Foss N, Lynch DH, Badley AD.

J Virol. 2001 Nov;75(22):11128-36.

18.

Immune-mediated phagocytosis and killing of Streptococcus pneumoniae are associated with direct and bystander macrophage apoptosis.

Dockrell DH, Lee M, Lynch DH, Read RC.

J Infect Dis. 2001 Sep 15;184(6):713-22. Epub 2001 Aug 24.

PMID:
11517432
19.

Mechanisms of HIV-associated lymphocyte apoptosis.

Badley AD, Pilon AA, Landay A, Lynch DH.

Blood. 2000 Nov 1;96(9):2951-64. Review.

PMID:
11049971
20.

Polyethylene glycol-modified GM-CSF expands CD11b(high)CD11c(high) but notCD11b(low)CD11c(high) murine dendritic cells in vivo: a comparative analysis with Flt3 ligand.

Daro E, Pulendran B, Brasel K, Teepe M, Pettit D, Lynch DH, Vremec D, Robb L, Shortman K, McKenna HJ, Maliszewski CR, Maraskovsky E.

J Immunol. 2000 Jul 1;165(1):49-58.

21.

Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells.

McKenna HJ, Stocking KL, Miller RE, Brasel K, De Smedt T, Maraskovsky E, Maliszewski CR, Lynch DH, Smith J, Pulendran B, Roux ER, Teepe M, Lyman SD, Peschon JJ.

Blood. 2000 Jun 1;95(11):3489-97.

PMID:
10828034
22.

Activation-induced CD4+ T cell death in HIV-positive individuals correlates with Fas susceptibility, CD4+ T cell count, and HIV plasma viral copy number.

Dockrell DH, Badley AD, Algeciras-Schimnich A, Simpson M, Schut R, Lynch DH, Paya CV.

AIDS Res Hum Retroviruses. 1999 Nov 20;15(17):1509-18.

PMID:
10580401
23.

Fas ligand promotes cell survival of immature human bone marrow CD34+CD38- hematopoietic progenitor cells by suppressing apoptosis.

Josefsen D, Myklebust JH, Lynch DH, Stokke T, Blomhoff HK, Smeland EB.

Exp Hematol. 1999 Sep;27(9):1451-9.

PMID:
10480436
24.

Synergistic action of fms-like tyrosine kinase 3 ligand and CD40 ligand in the induction of dendritic cells and generation of antitumor immunity in vivo.

Borges L, Miller RE, Jones J, Ariail K, Whitmore J, Fanslow W, Lynch DH.

J Immunol. 1999 Aug 1;163(3):1289-97.

25.

Dynamic correlation of apoptosis and immune activation during treatment of HIV infection.

Badley AD, Parato K, Cameron DW, Kravcik S, Phenix BN, Ashby D, Kumar A, Lynch DH, Tschopp J, Angel JB.

Cell Death Differ. 1999 May;6(5):420-32.

26.

Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis.

Algeciras-Schimnich A, Griffith TS, Lynch DH, Paya CV.

J Immunol. 1999 May 1;162(9):5205-11.

27.

Functional analysis of TRAIL receptors using monoclonal antibodies.

Griffith TS, Rauch CT, Smolak PJ, Waugh JY, Boiani N, Lynch DH, Smith CA, Goodwin RG, Kubin MZ.

J Immunol. 1999 Mar 1;162(5):2597-605.

28.

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M, Chin W, Jones J, Woodward A, Le T, Smith C, Smolak P, Goodwin RG, Rauch CT, Schuh JC, Lynch DH.

Nat Med. 1999 Feb;5(2):157-63.

PMID:
9930862
29.

TRAIL: a molecule with multiple receptors and control mechanisms.

Griffith TS, Lynch DH.

Curr Opin Immunol. 1998 Oct;10(5):559-63. Review.

PMID:
9794836
31.

Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells.

Griffith TS, Chin WA, Jackson GC, Lynch DH, Kubin MZ.

J Immunol. 1998 Sep 15;161(6):2833-40.

32.

In vivo analysis of Fas/FasL interactions in HIV-infected patients.

Badley AD, Dockrell DH, Algeciras A, Ziesmer S, Landay A, Lederman MM, Connick E, Kessler H, Kuritzkes D, Lynch DH, Roche P, Yagita H, Paya CV.

J Clin Invest. 1998 Jul 1;102(1):79-87.

33.

The expression of Fas Ligand by macrophages and its upregulation by human immunodeficiency virus infection.

Dockrell DH, Badley AD, Villacian JS, Heppelmann CJ, Algeciras A, Ziesmer S, Yagita H, Lynch DH, Roche PC, Leibson PJ, Paya CV.

J Clin Invest. 1998 Jun 1;101(11):2394-405.

34.
35.

Receptors and ligands that mediate activation-induced death of T cells.

Alderson MR, Lynch DH.

Springer Semin Immunopathol. 1998;19(3):289-300. Review. No abstract available.

PMID:
9540157
36.

CD4 regulates susceptibility to Fas ligand- and tumor necrosis factor-mediated apoptosis.

Algeciras A, Dockrell DH, Lynch DH, Paya CV.

J Exp Med. 1998 Mar 2;187(5):711-20.

37.

Human purified protein derivative-specific CD4+ T cells use both CD95-dependent and CD95-independent cytolytic mechanisms.

Lewinsohn DM, Bement TT, Xu J, Lynch DH, Grabstein KH, Reed SG, Alderson MR.

J Immunol. 1998 Mar 1;160(5):2374-9.

38.

CD40 ligand inhibits Fas/CD95-mediated apoptosis of human blood-derived dendritic cells.

Koppi TA, Tough-Bement T, Lewinsohn DM, Lynch DH, Alderson MR.

Eur J Immunol. 1997 Dec;27(12):3161-5.

PMID:
9464801
39.
40.
41.

Characterization of poly(glycolide-co-D,L-lactide)/poly(D,L-lactide) microspheres for controlled release of GM-CSF.

Pettit DK, Lawter JR, Huang WJ, Pankey SC, Nightlinger NS, Lynch DH, Schuh JA, Morrissey PJ, Gombotz WR.

Pharm Res. 1997 Oct;14(10):1422-30.

PMID:
9358556
42.

ZAP-70 tyrosine kinase is required for the up-regulation of Fas ligand in activation-induced T cell apoptosis.

Eischen CM, Williams BL, Zhang W, Samelson LE, Lynch DH, Abraham RT, Leibson PJ.

J Immunol. 1997 Aug 1;159(3):1135-9.

PMID:
9233606
43.

Fas-mediated cytotoxicity by intestinal intraepithelial lymphocytes during acute graft-versus-host disease in mice.

Sakai T, Kimura Y, Inagaki-Ohara K, Kusugami K, Lynch DH, Yoshikai Y.

Gastroenterology. 1997 Jul;113(1):168-74.

PMID:
9207275
44.

Fas ligand (CD95L) and B7 expression on dendritic cells provide counter-regulatory signals for T cell survival and proliferation.

Lu L, Qian S, Hershberger PA, Rudert WA, Lynch DH, Thomson AW.

J Immunol. 1997 Jun 15;158(12):5676-84.

PMID:
9190916
45.

Regulation of Fas and Fas-ligand expression in NK cells by cytokines and the involvement of Fas-ligand in NK/LAK cell-mediated cytotoxicity.

Medvedev AE, Johnsen AC, Haux J, Steinkjer B, Egeberg K, Lynch DH, Sundan A, Espevik T.

Cytokine. 1997 Jun;9(6):394-404.

PMID:
9199873
47.

Flt3 ligand induces tumor regression and antitumor immune responses in vivo.

Lynch DH, Andreasen A, Maraskovsky E, Whitmore J, Miller RE, Schuh JC.

Nat Med. 1997 Jun;3(6):625-31.

PMID:
9176488
48.

Blocking of the B7-CD28 pathway increases apoptosis induced in activated T cells by in vitro-generated CD95L (FasL) positive dendritic cells.

Lu L, Qian S, Hershberger P, Rudert WA, Li Y, Chambers FG, Starzl TE, Lynch DH, Thomson AW.

Transplant Proc. 1997 Feb-Mar;29(1-2):1094-5. No abstract available.

49.

Macrophage-dependent apoptosis of CD4+ T lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factor.

Badley AD, Dockrell D, Simpson M, Schut R, Lynch DH, Leibson P, Paya CV.

J Exp Med. 1997 Jan 6;185(1):55-64.

50.

Blocking of the B7-CD28 pathway increases the capacity of FasL+ (CD95L+) dendritic cells to kill alloactivated T cells.

Lu L, Qian S, Starzl TE, Lynch DH, Thomson AW.

Adv Exp Med Biol. 1997;417:275-82. No abstract available.

PMID:
9286373

Supplemental Content

Loading ...
Support Center